Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Capital Expenditures (2018 - 2025)

Autolus Therapeutics' Capital Expenditures history spans 5 years, with the latest figure at -$18.8 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 104.65% year-over-year to -$18.8 million; the TTM value through Dec 2025 reached $1.2 million, down 35.19%, while the annual FY2025 figure was $1.2 million, 35.19% down from the prior year.
  • Capital Expenditures reached -$18.8 million in Q4 2025 per AUTL's latest filing, down from $4.4 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $9.6 million in Q4 2022 to a low of -$18.8 million in Q4 2025.
  • Average Capital Expenditures over 4 years is $1.8 million, with a median of $3.7 million recorded in 2023.
  • Peak YoY movement for Capital Expenditures: plummeted 720.85% in 2024, then surged 1385.23% in 2025.
  • A 4-year view of Capital Expenditures shows it stood at $9.6 million in 2022, then plummeted by 84.65% to $1.5 million in 2023, then tumbled by 720.85% to -$9.2 million in 2024, then tumbled by 104.65% to -$18.8 million in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Capital Expenditures are -$18.8 million (Q4 2025), $4.4 million (Q3 2025), and $7.3 million (Q2 2025).